Skinvisible (SKVI) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Powered by 
Analysis
Skinvisible (SKVI) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -1.75% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -7.51% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -26.54% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 59.44% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 75.30% |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | -5.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.49% |
| Mar 31, 2026 | -113.05% |
| Dec 31, 2025 | -25.12% |
| Sep 30, 2025 | -18.98% |
| Jun 30, 2025 | -73.58% |
| Mar 31, 2025 | -53.36% |
| Dec 31, 2024 | -90.06% |
| Sep 30, 2024 | -203.33% |
| Jun 30, 2024 | -62.59% |
| Mar 31, 2024 | -29.08% |
| Dec 31, 2023 | -305.99% |
| Sep 30, 2023 | -16.76% |
| Jun 30, 2023 | -151.11% |
| Mar 31, 2023 | 40.29% |
| Dec 31, 2022 | -2.16% |
| Sep 30, 2022 | 0.91% |
| Jun 30, 2022 | 43.28% |
| Mar 31, 2022 | 27.58% |
| Dec 31, 2021 | 32.78% |
| Sep 30, 2021 | 46.97% |